Global Ophthalmic Devices and Drugs Market 2023 by Company, Regions, Type and Application, Forecast to 2029

1 Market Overview

• 1.1 Product Overview and Scope of Ophthalmic Devices and Drugs
• 1.2 Market Estimation Caveats and Base Year
• 1.3 Classification of Ophthalmic Devices and Drugs by Type
  • 1.3.1 Overview: Global Ophthalmic Devices and Drugs Market Size by Type: 2018 Versus 2022 Versus 2029
  • 1.3.2 Global Ophthalmic Devices and Drugs Consumption Value Market Share by Type in 2022
  • 1.3.3 Ophthalmic Devices
  • 1.3.4 Ophthalmic Drugs
• 1.4 Global Ophthalmic Devices and Drugs Market by Application
  • 1.4.1 Overview: Global Ophthalmic Devices and Drugs Market Size by Application: 2018 Versus 2022 Versus 2029
  • 1.4.2 Hospital
  • 1.4.3 Clinic
  • 1.4.4 Others
• 1.5 Global Ophthalmic Devices and Drugs Market Size & Forecast
• 1.6 Global Ophthalmic Devices and Drugs Market Size and Forecast by Region
  • 1.6.1 Global Ophthalmic Devices and Drugs Market Size by Region: 2018 VS 2022 VS 2029
  • 1.6.2 Global Ophthalmic Devices and Drugs Market Size by Region, (2018-2029)
  • 1.6.3 North America Ophthalmic Devices and Drugs Market Size and Prospect (2018-2029)
  • 1.6.4 Europe Ophthalmic Devices and Drugs Market Size and Prospect (2018-2029)
  • 1.6.5 Asia-Pacific Ophthalmic Devices and Drugs Market Size and Prospect (2018-2029)
  • 1.6.6 South America Ophthalmic Devices and Drugs Market Size and Prospect (2018-2029)
  • 1.6.7 Middle East and Africa Ophthalmic Devices and Drugs Market Size and Prospect (2018-2029)

2 Company Profiles

• 2.1 Zeiss
  • 2.1.1 Zeiss Details
  • 2.1.2 Zeiss Major Business
  • 2.1.3 Zeiss Ophthalmic Devices and Drugs Product and Solutions
  • 2.1.4 Zeiss Ophthalmic Devices and Drugs Revenue, Gross Margin and Market Share (2018-2023)
  • 2.1.5 Zeiss Recent Developments and Future Plans
• 2.2 Haag Streit
  • 2.2.1 Haag Streit Details
  • 2.2.2 Haag Streit Major Business
  • 2.2.3 Haag Streit Ophthalmic Devices and Drugs Product and Solutions
  • 2.2.4 Haag Streit Ophthalmic Devices and Drugs Revenue, Gross Margin and Market Share (2018-2023)
  • 2.2.5 Haag Streit Recent Developments and Future Plans
• 2.3 Topcon
  • 2.3.1 Topcon Details
  • 2.3.2 Topcon Major Business
  • 2.3.3 Topcon Ophthalmic Devices and Drugs Product and Solutions
  • 2.3.4 Topcon Ophthalmic Devices and Drugs Revenue, Gross Margin and Market Share (2018-2023)
  • 2.3.5 Topcon Recent Developments and Future Plans
• 2.4 Nidek
  • 2.4.1 Nidek Details
  • 2.4.2 Nidek Major Business
  • 2.4.3 Nidek Ophthalmic Devices and Drugs Product and Solutions
  • 2.4.4 Nidek Ophthalmic Devices and Drugs Revenue, Gross Margin and Market Share (2018-2023)
  • 2.4.5 Nidek Recent Developments and Future Plans
• 2.5 Essilor
  • 2.5.1 Essilor Details
  • 2.5.2 Essilor Major Business
  • 2.5.3 Essilor Ophthalmic Devices and Drugs Product and Solutions
  • 2.5.4 Essilor Ophthalmic Devices and Drugs Revenue, Gross Margin and Market Share (2018-2023)
  • 2.5.5 Essilor Recent Developments and Future Plans
• 2.6 Ziemer
  • 2.6.1 Ziemer Details
  • 2.6.2 Ziemer Major Business
  • 2.6.3 Ziemer Ophthalmic Devices and Drugs Product and Solutions
  • 2.6.4 Ziemer Ophthalmic Devices and Drugs Revenue, Gross Margin and Market Share (2018-2023)
  • 2.6.5 Ziemer Recent Developments and Future Plans
• 2.7 Canon
  • 2.7.1 Canon Details
  • 2.7.2 Canon Major Business
  • 2.7.3 Canon Ophthalmic Devices and Drugs Product and Solutions
  • 2.7.4 Canon Ophthalmic Devices and Drugs Revenue, Gross Margin and Market Share (2018-2023)
  • 2.7.5 Canon Recent Developments and Future Plans
• 2.8 Gulden Ophthalmics
  • 2.8.1 Gulden Ophthalmics Details
  • 2.8.2 Gulden Ophthalmics Major Business
  • 2.8.3 Gulden Ophthalmics Ophthalmic Devices and Drugs Product and Solutions
  • 2.8.4 Gulden Ophthalmics Ophthalmic Devices and Drugs Revenue, Gross Margin and Market Share (2018-2023)
  • 2.8.5 Gulden Ophthalmics Recent Developments and Future Plans
• 2.9 Optovue
  • 2.9.1 Optovue Details
  • 2.9.2 Optovue Major Business
  • 2.9.3 Optovue Ophthalmic Devices and Drugs Product and Solutions
  • 2.9.4 Optovue Ophthalmic Devices and Drugs Revenue, Gross Margin and Market Share (2018-2023)
  • 2.9.5 Optovue Recent Developments and Future Plans
• 2.10 Quest Medical
  • 2.10.1 Quest Medical Details
  • 2.10.2 Quest Medical Major Business
  • 2.10.3 Quest Medical Ophthalmic Devices and Drugs Product and Solutions
  • 2.10.4 Quest Medical Ophthalmic Devices and Drugs Revenue, Gross Margin and Market Share (2018-2023)
  • 2.10.5 Quest Medical Recent Developments and Future Plans
• 2.11 Phoenix DeVentures
  • 2.11.1 Phoenix DeVentures Details
  • 2.11.2 Phoenix DeVentures Major Business
  • 2.11.3 Phoenix DeVentures Ophthalmic Devices and Drugs Product and Solutions
  • 2.11.4 Phoenix DeVentures Ophthalmic Devices and Drugs Revenue, Gross Margin and Market Share (2018-2023)
  • 2.11.5 Phoenix DeVentures Recent Developments and Future Plans
• 2.12 EyeKon Medical
  • 2.12.1 EyeKon Medical Details
  • 2.12.2 EyeKon Medical Major Business
  • 2.12.3 EyeKon Medical Ophthalmic Devices and Drugs Product and Solutions
  • 2.12.4 EyeKon Medical Ophthalmic Devices and Drugs Revenue, Gross Margin and Market Share (2018-2023)
  • 2.12.5 EyeKon Medical Recent Developments and Future Plans
• 2.13 FCI Ophthalmics
  • 2.13.1 FCI Ophthalmics Details
  • 2.13.2 FCI Ophthalmics Major Business
  • 2.13.3 FCI Ophthalmics Ophthalmic Devices and Drugs Product and Solutions
  • 2.13.4 FCI Ophthalmics Ophthalmic Devices and Drugs Revenue, Gross Margin and Market Share (2018-2023)
  • 2.13.5 FCI Ophthalmics Recent Developments and Future Plans
• 2.14 Atrion
  • 2.14.1 Atrion Details
  • 2.14.2 Atrion Major Business
  • 2.14.3 Atrion Ophthalmic Devices and Drugs Product and Solutions
  • 2.14.4 Atrion Ophthalmic Devices and Drugs Revenue, Gross Margin and Market Share (2018-2023)
  • 2.14.5 Atrion Recent Developments and Future Plans
• 2.15 Sterimedix
  • 2.15.1 Sterimedix Details
  • 2.15.2 Sterimedix Major Business
  • 2.15.3 Sterimedix Ophthalmic Devices and Drugs Product and Solutions
  • 2.15.4 Sterimedix Ophthalmic Devices and Drugs Revenue, Gross Margin and Market Share (2018-2023)
  • 2.15.5 Sterimedix Recent Developments and Future Plans
• 2.16 OPIA
  • 2.16.1 OPIA Details
  • 2.16.2 OPIA Major Business
  • 2.16.3 OPIA Ophthalmic Devices and Drugs Product and Solutions
  • 2.16.4 OPIA Ophthalmic Devices and Drugs Revenue, Gross Margin and Market Share (2018-2023)
  • 2.16.5 OPIA Recent Developments and Future Plans
• 2.17 IRIDEX
  • 2.17.1 IRIDEX Details
  • 2.17.2 IRIDEX Major Business
  • 2.17.3 IRIDEX Ophthalmic Devices and Drugs Product and Solutions
  • 2.17.4 IRIDEX Ophthalmic Devices and Drugs Revenue, Gross Margin and Market Share (2018-2023)
  • 2.17.5 IRIDEX Recent Developments and Future Plans
• 2.18 Jardon Eye Prosthetics
  • 2.18.1 Jardon Eye Prosthetics Details
  • 2.18.2 Jardon Eye Prosthetics Major Business
  • 2.18.3 Jardon Eye Prosthetics Ophthalmic Devices and Drugs Product and Solutions
  • 2.18.4 Jardon Eye Prosthetics Ophthalmic Devices and Drugs Revenue, Gross Margin and Market Share (2018-2023)
  • 2.18.5 Jardon Eye Prosthetics Recent Developments and Future Plans
• 2.19 Santen Pharmaceutical
  • 2.19.1 Santen Pharmaceutical Details
  • 2.19.2 Santen Pharmaceutical Major Business
  • 2.19.3 Santen Pharmaceutical Ophthalmic Devices and Drugs Product and Solutions
  • 2.19.4 Santen Pharmaceutical Ophthalmic Devices and Drugs Revenue, Gross Margin and Market Share (2018-2023)
  • 2.19.5 Santen Pharmaceutical Recent Developments and Future Plans
• 2.20 Bausch Health
  • 2.20.1 Bausch Health Details
  • 2.20.2 Bausch Health Major Business
  • 2.20.3 Bausch Health Ophthalmic Devices and Drugs Product and Solutions
  • 2.20.4 Bausch Health Ophthalmic Devices and Drugs Revenue, Gross Margin and Market Share (2018-2023)
  • 2.20.5 Bausch Health Recent Developments and Future Plans
• 2.21 Takeda
  • 2.21.1 Takeda Details
  • 2.21.2 Takeda Major Business
  • 2.21.3 Takeda Ophthalmic Devices and Drugs Product and Solutions
  • 2.21.4 Takeda Ophthalmic Devices and Drugs Revenue, Gross Margin and Market Share (2018-2023)
  • 2.21.5 Takeda Recent Developments and Future Plans
• 2.22 Novartis
  • 2.22.1 Novartis Details
  • 2.22.2 Novartis Major Business
  • 2.22.3 Novartis Ophthalmic Devices and Drugs Product and Solutions
  • 2.22.4 Novartis Ophthalmic Devices and Drugs Revenue, Gross Margin and Market Share (2018-2023)
  • 2.22.5 Novartis Recent Developments and Future Plans
• 2.23 Genentech
  • 2.23.1 Genentech Details
  • 2.23.2 Genentech Major Business
  • 2.23.3 Genentech Ophthalmic Devices and Drugs Product and Solutions
  • 2.23.4 Genentech Ophthalmic Devices and Drugs Revenue, Gross Margin and Market Share (2018-2023)
  • 2.23.5 Genentech Recent Developments and Future Plans
• 2.24 Allergan
  • 2.24.1 Allergan Details
  • 2.24.2 Allergan Major Business
  • 2.24.3 Allergan Ophthalmic Devices and Drugs Product and Solutions
  • 2.24.4 Allergan Ophthalmic Devices and Drugs Revenue, Gross Margin and Market Share (2018-2023)
  • 2.24.5 Allergan Recent Developments and Future Plans
• 2.25 Sun Pharmaceutical Industries
  • 2.25.1 Sun Pharmaceutical Industries Details
  • 2.25.2 Sun Pharmaceutical Industries Major Business
  • 2.25.3 Sun Pharmaceutical Industries Ophthalmic Devices and Drugs Product and Solutions
  • 2.25.4 Sun Pharmaceutical Industries Ophthalmic Devices and Drugs Revenue, Gross Margin and Market Share (2018-2023)
  • 2.25.5 Sun Pharmaceutical Industries Recent Developments and Future Plans
• 2.26 Actavis Generics
  • 2.26.1 Actavis Generics Details
  • 2.26.2 Actavis Generics Major Business
  • 2.26.3 Actavis Generics Ophthalmic Devices and Drugs Product and Solutions
  • 2.26.4 Actavis Generics Ophthalmic Devices and Drugs Revenue, Gross Margin and Market Share (2018-2023)
  • 2.26.5 Actavis Generics Recent Developments and Future Plans
• 2.27 Regeneron Pharmaceuticals
  • 2.27.1 Regeneron Pharmaceuticals Details
  • 2.27.2 Regeneron Pharmaceuticals Major Business
  • 2.27.3 Regeneron Pharmaceuticals Ophthalmic Devices and Drugs Product and Solutions
  • 2.27.4 Regeneron Pharmaceuticals Ophthalmic Devices and Drugs Revenue, Gross Margin and Market Share (2018-2023)
  • 2.27.5 Regeneron Pharmaceuticals Recent Developments and Future Plans
• 2.28 Pfizer
  • 2.28.1 Pfizer Details
  • 2.28.2 Pfizer Major Business
  • 2.28.3 Pfizer Ophthalmic Devices and Drugs Product and Solutions
  • 2.28.4 Pfizer Ophthalmic Devices and Drugs Revenue, Gross Margin and Market Share (2018-2023)
  • 2.28.5 Pfizer Recent Developments and Future Plans
• 2.29 Johnson and Johnson
  • 2.29.1 Johnson and Johnson Details
  • 2.29.2 Johnson and Johnson Major Business
  • 2.29.3 Johnson and Johnson Ophthalmic Devices and Drugs Product and Solutions
  • 2.29.4 Johnson and Johnson Ophthalmic Devices and Drugs Revenue, Gross Margin and Market Share (2018-2023)
  • 2.29.5 Johnson and Johnson Recent Developments and Future Plans
• 2.30 Bausch and Lomb
  • 2.30.1 Bausch and Lomb Details
  • 2.30.2 Bausch and Lomb Major Business
  • 2.30.3 Bausch and Lomb Ophthalmic Devices and Drugs Product and Solutions
  • 2.30.4 Bausch and Lomb Ophthalmic Devices and Drugs Revenue, Gross Margin and Market Share (2018-2023)
  • 2.30.5 Bausch and Lomb Recent Developments and Future Plans

3 Market Competition, by Players

• 3.1 Global Ophthalmic Devices and Drugs Revenue and Share by Players (2018-2023)
• 3.2 Market Share Analysis (2022)
  • 3.2.1 Market Share of Ophthalmic Devices and Drugs by Company Revenue
  • 3.2.2 Top 3 Ophthalmic Devices and Drugs Players Market Share in 2022
  • 3.2.3 Top 6 Ophthalmic Devices and Drugs Players Market Share in 2022
• 3.3 Ophthalmic Devices and Drugs Market: Overall Company Footprint Analysis
  • 3.3.1 Ophthalmic Devices and Drugs Market: Region Footprint
  • 3.3.2 Ophthalmic Devices and Drugs Market: Company Product Type Footprint
  • 3.3.3 Ophthalmic Devices and Drugs Market: Company Product Application Footprint
• 3.4 New Market Entrants and Barriers to Market Entry
• 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

• 4.1 Global Ophthalmic Devices and Drugs Consumption Value and Market Share by Type (2018-2023)
• 4.2 Global Ophthalmic Devices and Drugs Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

• 5.1 Global Ophthalmic Devices and Drugs Consumption Value Market Share by Application (2018-2023)
• 5.2 Global Ophthalmic Devices and Drugs Market Forecast by Application (2024-2029)

6 North America

• 6.1 North America Ophthalmic Devices and Drugs Consumption Value by Type (2018-2029)
• 6.2 North America Ophthalmic Devices and Drugs Consumption Value by Application (2018-2029)
• 6.3 North America Ophthalmic Devices and Drugs Market Size by Country
  • 6.3.1 North America Ophthalmic Devices and Drugs Consumption Value by Country (2018-2029)
  • 6.3.2 United States Ophthalmic Devices and Drugs Market Size and Forecast (2018-2029)
  • 6.3.3 Canada Ophthalmic Devices and Drugs Market Size and Forecast (2018-2029)
  • 6.3.4 Mexico Ophthalmic Devices and Drugs Market Size and Forecast (2018-2029)

7 Europe

• 7.1 Europe Ophthalmic Devices and Drugs Consumption Value by Type (2018-2029)
• 7.2 Europe Ophthalmic Devices and Drugs Consumption Value by Application (2018-2029)
• 7.3 Europe Ophthalmic Devices and Drugs Market Size by Country
  • 7.3.1 Europe Ophthalmic Devices and Drugs Consumption Value by Country (2018-2029)
  • 7.3.2 Germany Ophthalmic Devices and Drugs Market Size and Forecast (2018-2029)
  • 7.3.3 France Ophthalmic Devices and Drugs Market Size and Forecast (2018-2029)
  • 7.3.4 United Kingdom Ophthalmic Devices and Drugs Market Size and Forecast (2018-2029)
  • 7.3.5 Russia Ophthalmic Devices and Drugs Market Size and Forecast (2018-2029)
  • 7.3.6 Italy Ophthalmic Devices and Drugs Market Size and Forecast (2018-2029)

8 Asia-Pacific

• 8.1 Asia-Pacific Ophthalmic Devices and Drugs Consumption Value by Type (2018-2029)
• 8.2 Asia-Pacific Ophthalmic Devices and Drugs Consumption Value by Application (2018-2029)
• 8.3 Asia-Pacific Ophthalmic Devices and Drugs Market Size by Region
  • 8.3.1 Asia-Pacific Ophthalmic Devices and Drugs Consumption Value by Region (2018-2029)
  • 8.3.2 China Ophthalmic Devices and Drugs Market Size and Forecast (2018-2029)
  • 8.3.3 Japan Ophthalmic Devices and Drugs Market Size and Forecast (2018-2029)
  • 8.3.4 South Korea Ophthalmic Devices and Drugs Market Size and Forecast (2018-2029)
  • 8.3.5 India Ophthalmic Devices and Drugs Market Size and Forecast (2018-2029)
  • 8.3.6 Southeast Asia Ophthalmic Devices and Drugs Market Size and Forecast (2018-2029)
  • 8.3.7 Australia Ophthalmic Devices and Drugs Market Size and Forecast (2018-2029)

9 South America

• 9.1 South America Ophthalmic Devices and Drugs Consumption Value by Type (2018-2029)
• 9.2 South America Ophthalmic Devices and Drugs Consumption Value by Application (2018-2029)
• 9.3 South America Ophthalmic Devices and Drugs Market Size by Country
  • 9.3.1 South America Ophthalmic Devices and Drugs Consumption Value by Country (2018-2029)
  • 9.3.2 Brazil Ophthalmic Devices and Drugs Market Size and Forecast (2018-2029)
  • 9.3.3 Argentina Ophthalmic Devices and Drugs Market Size and Forecast (2018-2029)

10 Middle East & Africa

• 10.1 Middle East & Africa Ophthalmic Devices and Drugs Consumption Value by Type (2018-2029)
• 10.2 Middle East & Africa Ophthalmic Devices and Drugs Consumption Value by Application (2018-2029)
• 10.3 Middle East & Africa Ophthalmic Devices and Drugs Market Size by Country
  • 10.3.1 Middle East & Africa Ophthalmic Devices and Drugs Consumption Value by Country (2018-2029)
  • 10.3.2 Turkey Ophthalmic Devices and Drugs Market Size and Forecast (2018-2029)
  • 10.3.3 Saudi Arabia Ophthalmic Devices and Drugs Market Size and Forecast (2018-2029)
  • 10.3.4 UAE Ophthalmic Devices and Drugs Market Size and Forecast (2018-2029)

11 Market Dynamics

• 11.1 Ophthalmic Devices and Drugs Market Drivers
• 11.2 Ophthalmic Devices and Drugs Market Restraints
• 11.3 Ophthalmic Devices and Drugs Trends Analysis
• 11.4 Porters Five Forces Analysis
  • 11.4.1 Threat of New Entrants
  • 11.4.2 Bargaining Power of Suppliers
  • 11.4.3 Bargaining Power of Buyers
  • 11.4.4 Threat of Substitutes
  • 11.4.5 Competitive Rivalry
• 11.5 Influence of COVID-19 and Russia-Ukraine War
  • 11.5.1 Influence of COVID-19
  • 11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

• 12.1 Ophthalmic Devices and Drugs Industry Chain
• 12.2 Ophthalmic Devices and Drugs Upstream Analysis
• 12.3 Ophthalmic Devices and Drugs Midstream Analysis
• 12.4 Ophthalmic Devices and Drugs Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology
• 14.2 Research Process and Data Source